Healthcare and Lifesciences
VedaCorp advises Smartvision, a leading eye care hospital chain in Telangana and Andhra Pradesh on its fund raise from Jashvik Capital-led Auresta Healthcare
About
Smartvision
Smartvision was started in 2015 and operates 14 eye hospitals across Telangana and Andhra Pradesh. It provides comprehensive range of services covering all ophthalmic subspecialties, including vision correction (e.g. laser eye surgery, refractive lens exchange), cataract surgery, glaucoma, and corneal and retinal conditions under one roof with wide spectrum of accurate diagnostics and treatments.
Jashvik Capital
Jashvik Capital is a mid-market sector focussed private equity firm investing across healthcare and consumer companies. They typically invest alongside founders of high-quality, profitable businesses in large addressable markets where there is an opportunity to undertake a transformative growth. For more information, visit https://jashvikcapital.com/
Background
We are pleased to announce that our client, Smart Vision Eye Specialities Private Limited (“Smartvision”) has successfully raised funding from Jashvik Capital, a healthcare and consumer focussed mid-market private equity investor through its eye care platform, Auresta Healthcare. Jashvik Capital has committed capital to do few similar sized eye care investments to build India’s leading eye care platform across multiple geographies.
Established in 2015 by Dr Harshavardhan Reddy, Smart Vision Eye Hospitals is one of the leading regional eye care chains in the southern states of Andhra Pradesh and Telangana. The company operates 14 centres in South India and offers a full suite of eye care services including refractive treatments and surgeries, cataract surgeries, treatments for retinal conditions, glaucoma, oculoplasty and pediatric eye care.
Veda Corporate Advisors (“VedaCorp”) was the exclusive financial advisor to the Company and its promoters. VedaCorp provided comprehensive transaction advisory services covering identification of prospective investors, strategic positioning including deal structuring, assistance in due diligence, negotiation and finalisation of key commercial terms, leading to the successful closure of the transaction.
“This marks VedaCorp’s 60th transaction in healthcare and life sciences space and 18th transaction in single specialty space.